908 Devices Inc (MASS) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
908 Devices inc   (NASDAQ: MASS)

Select the Financial Report: Select the Period:


Description of 908 Devices Inc's Business Segments


908 Devices Inc. is a company specializing in innovative analytical devices and software solutions for chemical analysis, particularly in the field of mass spectrometry. Founded with the aim of simplifying complex analytical tasks and making chemical analysis more accessible, 908 Devices has developed a range of products and services characterized by compactness, portability, and ease of use. Below is an extensive description of their segments, products, and services.

Segments

1. Industrial Applications:
- Manufacturing: 908 Devices offers solutions for process optimization and quality assurance in sectors like pharmaceuticals and chemicals.
- Energy: Their devices help in analyzing the composition of fuels and petrochemical products, aiding in regulatory compliance and safety.

2. Public Safety:
- Forensics: Portable mass spectrometers enable law enforcement and forensic teams to quickly analyze chemical substances in the field, enhancing rapid decision-making during investigations.
- Hazardous Materials Response: Devices are designed for first responders to assess threats from hazardous chemicals and identify unknown substances in real-time.

3. Research & Development:
- Academic and Industrial Research: 908 Devices provides analytical tools that facilitate research in various disciplines, from chemistry to environmental science.

4. Life Sciences:
- Clinical Applications: Their instrumentation can be integrated into clinical settings for immediate analysis of biological samples, aiding in diagnostics and treatment assessments.

Products

1. Mass Spectrometry Devices:
- M908: A portable mass spectrometer designed for field use in chemical identification and analysis. Features include:
- Real-time results for swift decision-making.
- Lightweight and battery-operated for mobility in the field.
- REBEL: A handheld mass spectrometry device engineered for first responders, offering critical analysis capabilities for identifying chemical threats quickly and accurately.

2. Software Solutions:
- Data Analytics: 908 Devices includes proprietary software that enhances the analysis capabilities of their devices, featuring algorithms for real-time data interpretation and reporting.
- User Interfaces: Simplified user interfaces are provided with their products to facilitate operation for those with limited technical training.

3. Sample Preparation Kits:
- Tailored kits designed to prepare environmental, biological, or industrial samples to enhance the accuracy and reliability of mass spectrometric analysis.

4. Accessories and Consumables:
- Essential items such as calibration standards, cleaning kits, and replacement parts to maintain the performance and longevity of their analytical devices.

Services

1. Training and Support:
- Providing comprehensive training programs for end-users to ensure effective use of their devices, alongside ongoing technical support services.

2. Consultative Services:
- Offering expertise in implementing integrated analytical solutions across various sectors, helping organizations optimize their analytical workflows.

3. Custom Solutions:
- Collaboration with clients to develop tailored solutions that fit specific needs or operational challenges in their analytical processes.

4. Maintenance and Calibration:
- Regular maintenance and calibration services to ensure devices operate within required specifications and provide accurate analytical results.

Conclusion

908 Devices Inc. continues to be at the forefront of analytical technology by offering a diverse suite of products and services tailored for various industries. Their focus on portability, ease of use, and rapid data analysis positions them as a key player in making advanced mass spectrometry accessible to a broader audience, from industrial labs to emergency response teams.


Composition of 908 Devices inc Revenues by Segments

 
United States    82.27 % of total Revenue
Europe Middle East and Africa    8.76 % of total Revenue
Asia Pacific    4.5 % of total Revenue
Americas other    8.34 % of total Revenue
United States federal and defense    25.3 % of total Revenue
United States State authorities and local municipalities    52.59 % of total Revenue
Rest of world national and provincial organizations    21.08 % of total Revenue
Global pharmaceutical industrial and other    4.91 % of total Revenue
Handheld product and service revenue    98.97 % of total Revenue
OEM and funded partnership revenue    4.91 % of total Revenue
Device sales revenue    72.66 % of total Revenue
Recurring revenue    31.21 % of total Revenue
Single reportable segment    103.87 % of total Revenue

Q1 three months ended (Mar 31 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
United States 10.60 82.27 %
Europe Middle East and Africa 1.13 8.76 %
Asia Pacific 0.58 4.5 %
Americas other 1.08 8.34 %
United States federal and defense 3.26 25.3 %
United States State authorities and local municipalities 6.78 52.59 %
Rest of world national and provincial organizations 2.72 21.08 %
Global pharmaceutical industrial and other 0.63 4.91 %
Handheld product and service revenue 12.75 98.97 %
OEM and funded partnership revenue 0.63 4.91 %
Device sales revenue 9.36 72.66 %
Recurring revenue 4.02 31.21 %
Single reportable segment 13.38 103.87 %
Total 12.88 100 %




Q1 three months ended (Mar 31 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
United States 51.14 % -
Europe Middle East and Africa -74.67 % -
Asia Pacific 220.44 % -
Americas other 726.92 % -
United States federal and defense 88.49 % -
United States State authorities and local municipalities 44.55 % -
Rest of world national and provincial organizations -41.91 % -
Global pharmaceutical industrial and other -8.01 % -
Handheld product and service revenue 16.58 % -
OEM and funded partnership revenue -8.01 % -
Device sales revenue 26.3 % -
Recurring revenue -6.55 % -
Single reportable segment 13.62 % -
Total 11.62 % -76.76 %




Q1 three months ended (Mar 31 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -11.96 -




Q1 three months ended (Mar 31 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on 908 Devices inc Divisions, Sales by Country

 
United States   United States Segment contribution to total sales 74.43 % of total Revenue
Europe Middle East and Africa   Europe Middle East and Africa Segment contribution to total sales 18.81 % of total Revenue
Asia Pacific   Asia Pacific Segment contribution to total sales 5.41 % of total Revenue
Americas other   Americas other Segment contribution to total sales 2.75 % of total Revenue
United States federal and defense   United States federal and defense Segment contribution to total sales 26.23 % of total Revenue
United States State authorities and local municipalities   United States State authorities and local municipalities Segment contribution to total sales 43.73 % of total Revenue
Rest of world national and provincial organizations   Rest of world national and provincial organizations Segment contribution to total sales 26.05 % of total Revenue
Global pharmaceutical industrial and other   Global pharmaceutical industrial and other Segment contribution to total sales 5.39 % of total Revenue
Handheld product and service revenue   Handheld product and service revenue Segment contribution to total sales 95.35 % of total Revenue
OEM and funded partnership revenue   OEM and funded partnership revenue Segment contribution to total sales 5.14 % of total Revenue
Device sales revenue   Device sales revenue Segment contribution to total sales 66.15 % of total Revenue
Recurring revenue   Recurring revenue Segment contribution to total sales 35.04 % of total Revenue
Program product and service revenue   Program product and service revenue Segment contribution to total sales 0.91 % of total Revenue
Contract revenue   Contract revenue Segment contribution to total sales 0.21 % of total Revenue


Twelve months ended 2025
MASS s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
United States 41.25 74.43 %
Europe Middle East and Africa 10.43 18.81 %
Asia Pacific 3.00 5.41 %
Americas other 1.53 2.75 %
United States federal and defense 14.54 26.23 %
United States State authorities and local municipalities 24.24 43.73 %
Rest of world national and provincial organizations 14.44 26.05 %
Global pharmaceutical industrial and other 2.99 5.39 %
Handheld product and service revenue 52.84 95.35 %
OEM and funded partnership revenue 2.85 5.14 %
Device sales revenue 36.66 66.15 %
Recurring revenue 19.42 35.04 %
Total 55.42 100 %
Program product and service revenue 0.50 0.91 %
Contract revenue 0.12 0.21 %


Twelve months ended 2025
MASS s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 19.49 35.16 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
United States 15.72 % -
Europe Middle East and Africa 14.16 % -
Asia Pacific 42.53 % -
Americas other 76.71 % -
United States federal and defense -13.57 % -
United States State authorities and local municipalities 38.2 % -
Rest of world national and provincial organizations 21.46 % -
Global pharmaceutical industrial and other 98.6 % -
Handheld product and service revenue 20.14 % -
OEM and funded partnership revenue 74.16 % -
Device sales revenue 15.7 % -
Recurring revenue 21.92 % -
Total -5.83 % -
Program product and service revenue -76.38 % -
Contract revenue -11.36 % -
Product and service revenue - -
Product and service revenue Government - -
Product and service revenue Pharmaceutical Biotechnology - -
Product and service revenue Academia and other - -
Product and service revenue Handheld - -
Product and service revenue Desktop - -
Device sales revenue Handheld - -
Device sales revenue Desktop - -
Recurring revenue Handheld - -
Recurring revenue Desktop - -
Contract revenue Handheld - -
Contract revenue Desktop - -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.